Immune Responses to AAV in Canine Muscle Monitored by Cellular Assays and Noninvasive Imaging
Open Access
- 1 March 2010
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 18 (3) , 617-624
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cellsBlood, 2009
- Evaluation of Vascular Delivery Methodologies to Enhance rAAV6-mediated Gene Transfer to Canine Striated MusculatureMolecular Therapy, 2009
- Limb‐girdle muscular dystrophy type 2D gene therapy restores α‐sarcoglycan and associated proteinsAnnals of Neurology, 2009
- Sustained AAV-mediated Dystrophin Expression in a Canine Model of Duchenne Muscular Dystrophy with a Brief Course of ImmunosuppressionMolecular Therapy, 2007
- Immunity to Adeno-Associated Virus-Mediated Gene Transfer in a Random-Bred Canine Model of Duchenne Muscular DystrophyHuman Gene Therapy, 2007
- Single Amino Acid Changes Can Influence Titer, Heparin Binding, and Tissue Tropism in Different Adeno-Associated Virus SerotypesJournal of Virology, 2006
- Treatment of human disease by adeno-associated viral gene transferHuman Genetics, 2006
- Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6Molecular Therapy, 2004
- Noninvasive monitoring of stem cell transfer for muscle disordersMagnetic Resonance in Medicine, 2004
- Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adultsJournal of Neurology, 1994